drugset / Trial / NCT01566942

FOLFIRI or mFOLFOX6 in Adjuvant Chemotherapy in Advanced Colorectal Cancer

NCT01566942 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

the aim of this study is to observe the effect of irinotecan-based regimen in patients with advanced colorectal cancer.

Timeline

Start
2012-06
Primary completion
2014-05
Completion
2017-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Irinotecan Small molecule 180 mg/m2 —
Comparator Oxaliplatin Small molecule 85 mg/m2 —

Indications